MiMedx Group, Inc (MDXG) vs Verastem, Inc. (VSTM)
MiMedx Group, Inc and Verastem, Inc. are both Biotechnology companies. MiMedx Group, Inc and Verastem, Inc. are of similar size ($694.6M and $686.5M). Verastem, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 117×. Verastem, Inc. grew revenue faster over the last twelve months: 472.9% against −2.36%. MiMedx Group, Inc has the higher net margin (1.76% vs −231.6%) and the higher return on invested capital (5.62% vs 0.00%). Across the 18 metrics below, MiMedx Group, Inc leads on 14 and Verastem, Inc. on 4.
Valuation
Profitability
| Metric | MDXG | VSTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.85% | 86.35% | 65.16% |
| Operating margin | 2.46% | (182.57%) | 0.00% |
| Net margin | 1.76% | (231.59%) | 0.00% |
| Free cash flow margin | 12.51% | (185.31%) | 0.00% |
| Return on equity | 2.88% | (471.16%) | (57.72%) |
| Return on assets | 2.18% | (100.65%) | (49.22%) |
| Return on invested capital | 5.62% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack